Advanced Biomedical Technologies
ABMT · OTC
$0.0005+$0.0095 (−105.56%)TodayMarket closed ·
No price history for this range.
Key indicators
ABMT profitability and balance sheet ratios
EPS -$0.0028 in Jul 2021, against -$0.0029 a year earlier.
| Period | EPS |
|---|---|
| Oct 2019 | -$0.0036 |
| Jan 2020 | -$0.0009 |
| Apr 2020 | -$0.003 |
| Jul 2020 | -$0.0029 |
| Oct 2020 | -$0.0028 |
| Jan 2021 | -$0.0024 |
| Apr 2021 | -$0.0027 |
| Jul 2021 | -$0.0028 |
Income statement
No financial statements are reported for Advanced Biomedical Technologies.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Jan 2021 | Apr 2021 | Jul 2021 |
|---|---|---|---|
| Total assets | $0.3M | $0.4M | $0.4M |
| Total liabilities | $8.2M | $8.3M | $8.6M |
| Shareholder equity | −$7.8M | −$8.0M | −$8.2M |
| Cash and short-term investments | $0.0M | $0.0M | $0.0M |
| Total debt | $6.1M | $6.3M | $6.3M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.